Cardiome Pharma (CRME) Appoints Doug Janzen as CEO

August 3, 2009 5:22 PM EDT Send to a Friend
Cardiome Pharma Corp. (NASDAQ: CRME) announced that Doug Janzen, formerly President ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login